Salmeterol Xinafoate

API Product
Salmeterol Xinafoate
Product Status:
Commercial
Available Grades:
  • 吸入剤用
Regulatory Status:
米国 DMF
欧州CEP
Production Sites:
  • Hovione Loures
Product Type:
  • LABA
  • LAMA
CAS Number:
94749-08-3
Modes of Application:
  • 吸入
Common Indications:
  • 喘息
  • 慢性閉塞性肺疾患
Last Inspection:
FDA May 2018

Hovione can customize Salmeterol Xinafoate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Salmeterol Xinafoate is approved in generic applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Fluticasone Propionate or Tiotropium Bromide.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties' patent rights.

Highlight

お問合せ

ありがとうございました。

https://go.hovione.com/l/47122/2015-09-14/21by7k

Related files

原薬一覧
pdf (323.82 KB)
Download